Enhancement of maximal activation of neuronal nitric oxide synthase at muscarinic M 1 receptors following prolonged agonist treatment

By Cuadra A.E.   El-Fakahany E.E.  

European Journal of Pharmacology, Vol. 334, Iss. 1, 1997-09 ,pp. : 107-110

Elsevier

Access to resources Recommend Favorite

Xanomeline in mild and moderate Alzheimer's disease; the effects of a novel M1 agonist on behavior

By Bodick N.C.   Offen W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 254-255

Elsevier

Access to resources Recommend Favorite

Binding of the labelled muscarinic toxin 125 I-MT1 to rat brain muscarinic M 1 receptors

By Waelbroeck M.   De Neef P.   Domenach V.   Vandermeers-Piret M.-C.   Vandermeers A.  

European Journal of Pharmacology, Vol. 305, Iss. 1, 1996-06 ,pp. : 187-192

Elsevier

Access to resources Recommend Favorite

Differential regulation of muscarinic M 1 and M 3 receptors by a putative phosphorylation domain

By Shockley M.S.   Tolbert L.M.   Tobin A.B.   Nahorski S.R.   Sadee W.   Lameh J.  

European Journal of Pharmacology, Vol. 377, Iss. 1, 1999-07 ,pp. : 137-146

Elsevier

Access to resources Recommend Favorite

Selective Activation of Muscarinic Acetylcholine Receptors for the Treatment of Schizophrenia

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1563-1571

Bentham Science Publishers

Access to resources Recommend Favorite